[go: up one dir, main page]

AU2003237460A1 - Combination treatments for purinoceptor-related disorders - Google Patents

Combination treatments for purinoceptor-related disorders

Info

Publication number
AU2003237460A1
AU2003237460A1 AU2003237460A AU2003237460A AU2003237460A1 AU 2003237460 A1 AU2003237460 A1 AU 2003237460A1 AU 2003237460 A AU2003237460 A AU 2003237460A AU 2003237460 A AU2003237460 A AU 2003237460A AU 2003237460 A1 AU2003237460 A1 AU 2003237460A1
Authority
AU
Australia
Prior art keywords
purinoceptor
related disorders
combination treatments
treatments
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003237460A
Other languages
English (en)
Inventor
Mark A. Sirgo
Constance N. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endacea Inc
Original Assignee
Endacea Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endacea Inc filed Critical Endacea Inc
Publication of AU2003237460A1 publication Critical patent/AU2003237460A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003237460A 2002-06-06 2003-06-06 Combination treatments for purinoceptor-related disorders Abandoned AU2003237460A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/386,769 2002-06-06
US38676902P 2002-06-07 2002-06-07
PCT/US2003/017964 WO2003103675A2 (fr) 2002-06-06 2003-06-06 Polytherapies destinees aux troubles lies aux purinocepteurs

Publications (1)

Publication Number Publication Date
AU2003237460A1 true AU2003237460A1 (en) 2003-12-22

Family

ID=29736207

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003237460A Abandoned AU2003237460A1 (en) 2002-06-06 2003-06-06 Combination treatments for purinoceptor-related disorders

Country Status (2)

Country Link
AU (1) AU2003237460A1 (fr)
WO (1) WO2003103675A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247639B2 (en) * 2003-06-06 2007-07-24 Endacea, Inc. A1 adenosine receptor antagonists
US20090068101A9 (en) * 2003-06-09 2009-03-12 Endacea, Inc. A1 Adenosine Receptor Antagonists
ES2223287B1 (es) * 2003-08-04 2006-04-16 Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea Compuestos para el tratamiento de enfermedades desmielinizantes y autoinmunes.
WO2005094885A1 (fr) * 2004-03-30 2005-10-13 Kyowa Hakko Kogyo Co., Ltd. Agent préventif et/ou thérapeutique pour une maladie accompagné d'une douleur chronique aux muscles ou au squelette
WO2009086077A2 (fr) 2007-12-21 2009-07-09 Endacea, Inc. Antagonistes des récepteurs de l'adénosine a1
US9877967B2 (en) * 2010-01-26 2018-01-30 Endacea, Inc. Methods and pharmaceutical compositions for preventing and treating renal impairment
IT202000015817A1 (it) * 2020-07-01 2022-01-01 Giampietro Iachettini Adenosina per l’uso nel trattamento di infezioni virali

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
US5733916A (en) * 1995-03-24 1998-03-31 The Trustees Of The University Of Pennsylvania Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists
WO1999034803A1 (fr) * 1998-01-09 1999-07-15 The Trustees Of The University Of Pennsylvania Compositions et traitements convenant pour les lesions tissulaires liees a la reperfusion d'une ischemie ou dues a des endotoxines
US6117445A (en) * 1998-01-28 2000-09-12 Link Technology Inc. Methods for the prevention and treatment of fibrosis and sclerosis
EP1390068A4 (fr) * 2001-05-18 2006-04-05 Endacea Inc Methodes et formules d'utilisation d'antagonistes des purinorecepteurs de l'adenosine a 1 et de p 2x

Also Published As

Publication number Publication date
WO2003103675A3 (fr) 2004-03-25
WO2003103675A2 (fr) 2003-12-18

Similar Documents

Publication Publication Date Title
AU2003282679A1 (en) Hydroxypyrazoles for use against metabolic-related disorders
AU2003224654A1 (en) Photodynamic therapy for pre-melanomas
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
WO2003072535A8 (fr) Hydroxyethylamines substituees
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003210597A1 (en) Methods for treating eye disorders
AU2003272902A1 (en) Remedies
AUPS160602A0 (en) Therapeutic method
AU2003247005A1 (en) Therapy combination
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2002353510A1 (en) Nebuliser
AU2003215150A1 (en) Therapeutic compounds
AU2003221050A1 (en) Remedy for hypermyotonia
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003237460A1 (en) Combination treatments for purinoceptor-related disorders
AU2003205898A1 (en) Combination therapy for respiratory disorders
AU2003272901A1 (en) Remedies
AU2003303949A1 (en) Treatments for leishmaniasis
AU2003214499A1 (en) Allyl-phenol compounds in androgenic disorders
AU2003234867A1 (en) Rollator
AU2003246977A1 (en) Oil well treatment
AU2003231937A1 (en) Therapeutic methods
AU2003228813A1 (en) Methods for treating neuronal disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase